Skip to main content
. 2011 May 20;11:4. doi: 10.1186/1472-6904-11-4

Table 3.

Treatment compliance

Compliance

50% 80%
ACE 66.4% 56.1%

ARB 68.1% 57.0%

β-blockers 71.1% 59.7%

Spironolactone 58.4%* 45.6%*

* Spironolactone versus ACE, ARB and β-blockers: p < 0.001 (Pearson's chi square test)